CLINICAL_TRIALS
trial_result
· 2025-03-07
Clinical Trial Update: Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma [EARLY_Phase 1]
Summary
The Phase 1 trial evaluating gemcitabine in newly diagnosed Diffuse Intrinsic Pontine Glioma has completed. The study was sponsored by the University of Colorad…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Colorado, Denver | Conditions: Diffuse Intrinsic Pontine Glioma | EARLY_Phase 1 | Status: COMPLETED